Search Results 91-100 of 16264 for Bordetella+pertussis
The eMERGE Genome Informed Risk Assessment study at Mayo Clinic outlines risk factors for nine common conditions for adult participants and four common ...
Sam Farres, M.D., Chair, Division of Vascular Surgery Mayo Clinic in Florida: Very broadly speaking, it can be divided into neurogenic thoracic outlet, if the ...
The purpose of this study is to evaluate the efficacy and safety of TGR-1202 both alone and in combination with ublituximab in the treatment of previously ...
Mayo Clinic's Joseph H. Butterfield, M.D., diagnoses and treats patients with mast cell disease and hypereosinophilic disorders.
Immunosuppressants · Cyclosporine (Gengraf, Neoral, Sandimmune). · Tacrolimus (Astagraf XL, Prograf, Envarsus XR).
The purpose of this study is to establish whether therapeutic-dose parenteral anticoagulation improves outcomes (reduces intubation or mortality) by 30 days ...
The Neurodegenerative Diseases Lab seeks to understand and prevent neuronal degeneration and death in diseases characterized by abnormal protein aggregation and ...
The purpose of this study is to characterize the mucosal microbiome in patients who have recently been treated for Clostridium-difficile Infection (CDI) in ...
Mayo Clinic offers healthcare professionals genome informed clinical recommendations related to the Electronic Medical Records and GEnomics (eMERGE) Network ...
Research. Ongoing research in Dr. Petrucelli's Neurodegenerative Diseases Lab centers on cellular mechanisms induced by the abnormal aggregation of specific ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.